$2.14
-0.165[-7.16%]
At close: May 10
$2.14
0[0.00%]
After Hours: 5:13PM EDT
BioXcel Therapeutics
(NASDAQ:BTAI)BioXcel Therapeutics Stock (NASDAQ:BTAI), Quotes and News Summary
BioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile.
| Open | $2.320 |
| Close | $2.090 |
| Volume / Avg. | 696.007K / 1.417M |
| Day Range | 2.050 - 2.330 |
| 52 Wk Range | 1.910 - 29.560 |
| Market Cap | $79.254M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 34 |
| Short Interest | 7.46% |
| Days to Cover | 4.98 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioXcel Therapeutics (BTAI) stock?
You can purchase shares of BioXcel Therapeutics (NASDAQ: BTAI) through any online brokerage.
Who are BioXcel Therapeutics's (BTAI) competitors?
Other companies in BioXcel Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Connect Biopharma Hldgs (NASDAQ:CNTB) and Burning Rock Biotech (NASDAQ:BNR).
What is the target price for BioXcel Therapeutics (BTAI) stock?
The latest price target for BioXcel Therapeutics (NASDAQ: BTAI) was reported by HC Wainwright & Co. on Friday, May 10, 2024. The analyst firm set a price target for 10.00 expecting BTAI to rise to within 12 months (a possible 367.29% upside). 25 analyst firms have reported ratings in the last year.
Current Stock Price for BioXcel Therapeutics (BTAI)?
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $2.14 last updated May 10, 2024 at 5:13 PM EDT.
Does BioXcel Therapeutics (BTAI) pay a dividend?
There are no upcoming dividends for BioXcel Therapeutics.
When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?
BioXcel Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is BioXcel Therapeutics (BTAI) going to split?
There is no upcoming split for BioXcel Therapeutics.
What sector and industry does BioXcel Therapeutics (BTAI) operate in?
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.